GENETIC SUSCEPTIBILITY TO VINYL CHLORIDE INDUCED CANCER
GENETIC SUSCEPTIBILITY TO VINYL CHLORIDE INDUCED CANCER
批准号:
2749712
负责人:
Roland Valdes
金额:
$21.21万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-08-01 至 2000-07-31
关键词:
N glycosidase angiosarcoma biomarker chemical carcinogen chemical related neoplasm /cancer clinical research cytochrome P450 disease /disorder proneness /risk gene environment interaction genetic polymorphism genetic promoter element glutathione transferase human genetic material tag human subject liver neoplasms methylpurine neoplasm /cancer genetics nucleic acid sequence phenotype polymerase chain reaction polyvinyls single strand conformation polymorphism
中文摘要
描述(改编自《调查者摘要》):长期
这项研究的目的是发展基于遗传的生物标记物分析。
用于识别因接触以下物质而增加健康风险的个人
致癌物质。具体的目标是确定遗传决定因素
氯乙烯-用作生物标志物的代谢和DNA损伤修复
评估氯乙烯诱发的肝癌的先验易感性
人类。肝血管肉瘤(ASL)将被用作工作模型。
ASL是一种致命的疾病,死亡率为100%。有一个
ASL与职业性氯乙烯接触密切相关
(VC)。ASL在广泛的氯乙烯范围内以恒定的速度发生
(VC)暴露,表明人类存在高危表型。
VC的诱变潜力受三个过程控制:1)它是
由细胞色素P4502E1(细胞色素P4502E1)介导的生物激活而增加,2)
通过谷胱甘肽S转移酶介导的结合降低
代谢产物为谷胱甘肽,以及,3)它通过甲基嘌呤-DNA还原。
糖基酶(MPG)启动的亚乙基DNA加合物的去除。该模型是
定义良好,因为它包括:接触到的对象的独特来源
Vc,ASL受试者的肝组织样本,具有良好的特征性
VC相关肿瘤细胞系,病原体(VC及其代谢物),
以及遗传易感性的可能性。调查人员的假设是
对VC诱导的肝脏血管肉瘤的易感性与
具有异常的CYP2E1、GST和/或MPG表型的遗传决定因素。至
评估这一假设,他们将:1)筛查ASL患者
可能导致高危的CYP2E1和MPG基因的特定突变
表型;2)开发方法对人群进行筛查
在ASL患者中发现的CYP2E1和MPG突变等位基因的患病率,以及,
3)确定CYP2E1、GST基因多态与/或
个人群体中的MPG与肝癌易感性
暴露在氯乙烯中。这项研究有望提供一种机制
要快速有效地识别目前在
乙烯基单体行业可能是感染VC诱导的ASL的高危人群。
它还将提供一个工作模型,用于评估CYP2E1、GST、
和MPG在暴露相关的健康结果中。结果将提供一个
基于遗传的模型,可用于研究各种其他引起的疾病
从环境暴露到外源生物。
英文摘要
DESCRIPTION (Adapted from the Investigator's Abstract): The long-term
objective of this research is to develop genetically-based biomarker assays
for identifying individuals with increased health-risk from exposure to
carcinogens. The specific objective is to identify genetic determinants of
vinyl chloride-metabolism and DNA lesion repair for use as biomarkers to
assess a priori susceptibility to vinyl chloride-induced liver cancer in
humans. Angiosarcoma of the liver (ASL) will be used as a working model.
ASL is a devastating disease with a 100% rate of mortality. There is a
strong association between ASL and occupational exposure to vinyl chloride
(VC). ASL occurs at a constant rate over a broad range of vinyl chloride
(VC) exposure, suggesting the existence of a high risk phenotype in humans.
The mutagenic potential of VC is controlled by three processes: 1) It is
increased by cytochrome P4502E1 (CYP2E1)-mediated bioactivation, 2) it is
decreased through glutathione S-transferase (GST)-mediated conjugation of
metabolites to glutathione, and, 3) it is decreased through methylpurine-DNA
glycosylase (MPG)-initiated removal of etheno-DNA adducts. The model is
well defined because it includes: a unique source of subjects exposed to
VC, liver tissue samples from subjects with ASL, a well characterized
VC-associated tumor cell line, the causative agent (VC and its metabolite),
and the likelihood of genetic susceptibility. The investigators hypothesize
that susceptibility to VC-induced angiosarcoma of the liver is associated
with genetic determinants of aberrant CYP2E1, GST and/or MPG phenotypes. To
evaluate this hypothesis, they will: 1) screen individuals with ASL for
specific mutations of the CYP2E1 and MPG genes which may lead to a high risk
phenotype; 2) develop methods to screen a human population for the
prevalence of CYP2E1 and MPG mutant alleles identified in ASL subjects, and,
3) determine the relationship between polymorphism in CYP2E1, GST, and/or
MPG and susceptibility to liver cancer in a population of individuals
exposed to vinyl chloride. This research is expected to provide a mechanism
to rapidly and effectively identify individuals currently working in the
vinyl monomer industry who may be at high risk for acquiring VC-induced ASL.
It will also provide a working model for assessing the role of CYP2E1, GST,
and MPG in exposure-linked health outcome. The results will provide a
genetic-based model useful in approaching a variety of other diseases caused
from environmental exposure to xenobiotics.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A Non-invasive Assay for Obstructive Sleep Apnea
-
批准号:9408287
-
项目类别:
-
资助金额:$22.46万
-
财政年份:2017
-
负责人:Roland Valdes
-
依托单位:
METABOLISM OF DIGITALIS LIKE FACTORS
-
批准号:6330142
-
项目类别:
-
资助金额:$28.71万
-
财政年份:1998
-
负责人:Roland Valdes
-
依托单位:
METABOLISM OF DIGITALIS LIKE FACTORS
-
批准号:2727391
-
项目类别:
-
资助金额:$32.68万
-
财政年份:1998
-
负责人:Roland Valdes
-
依托单位:
METABOLISM OF DIGITALIS LIKE FACTORS
-
批准号:6125854
-
项目类别:
-
资助金额:$27.89万
-
财政年份:1998
-
负责人:Roland Valdes
-
依托单位:
METABOLISM OF DIGITALIS LIKE FACTORS
-
批准号:6476821
-
项目类别:
-
资助金额:$29.43万
-
财政年份:1998
-
负责人:Roland Valdes
-
依托单位:
GENETIC SUSCEPTIBILITY TO VINYL CHLORIDE INDUCED CANCER
-
批准号:6353828
-
项目类别:
-
资助金额:$5.0万
-
财政年份:1997
-
负责人:Roland Valdes
-
依托单位:
GENETIC SUSCEPTIBILITY TO VINYL CHLORIDE INDUCED CANCER
-
批准号:2378004
-
项目类别:
-
资助金额:$22.67万
-
财政年份:1997
-
负责人:Roland Valdes
-
依托单位:
GENETIC SUSCEPTIBILITY TO VINYL CHLORIDE INDUCED CANCER
-
批准号:6043507
-
项目类别:
-
资助金额:$21.84万
-
财政年份:1997
-
负责人:Roland Valdes
-
依托单位:
ENDOGENOUS DIGOXIN-IMMUNOACTIVITY IN HYPERTENSIVE PREGNA
-
批准号:3352632
-
项目类别:
-
资助金额:$10.13万
-
财政年份:1989
-
负责人:Roland Valdes
-
依托单位:
CHARACTERIZATION OF HUMAN ENDOGENOUS DIGOXIN-LIKE FACTOR
-
批准号:3350922
-
项目类别:
-
资助金额:$3.48万
-
财政年份:1989
-
负责人:Roland Valdes
-
依托单位:
CHARACTERIZATION OF HUMAN ENDOGENOUS DIGOXIN-LIKE FACTOR
-
批准号:3350919
-
项目类别:
-
资助金额:$10.31万
-
财政年份:1987
-
负责人:Roland Valdes
-
依托单位:
CHARACTERIZATION OF HUMAN ENDOGENOUS DIGOXIN-LIKE FACTOR
-
批准号:3350920
-
项目类别:
-
资助金额:$12.97万
-
财政年份:1987
-
负责人:Roland Valdes
-
依托单位:
CHARACTERIZATION OF HUMAN ENDOGENOUS DIGOXIN-LIKE FACTOR
-
批准号:3350915
-
项目类别:
-
资助金额:$15.35万
-
财政年份:1987
-
负责人:Roland Valdes
-
依托单位:
PHYSIOLOGIC ROLE OF ENDOGENOUS DIGITALIS-LIKE FACTOR
-
批准号:3350921
-
项目类别:
-
资助金额:$19.51万
-
财政年份:1987
-
负责人:Roland Valdes
-
依托单位:
PHYSIOLOGIC ROLE OF ENDOGENOUS DIGITALIS-LIKE FACTOR
-
批准号:3350918
-
项目类别:
-
资助金额:$19.29万
-
财政年份:1987
-
负责人:Roland Valdes
-
依托单位:
PHYSIOLOGIC ROLE OF ENDOGENOUS DIGITALIS-LIKE FACTOR
-
批准号:2218092
-
项目类别:
-
资助金额:$20.24万
-
财政年份:1987
-
负责人:Roland Valdes
-
依托单位:
ENDOGENOUS DIGOXIN-IMMUNOACTIVITY/HYPERTENSIVE PREGNANCY
-
批准号:3352630
-
项目类别:
-
资助金额:$14.78万
-
财政年份:1986
-
负责人:Roland Valdes
-
依托单位:
ENDOGENOUS DIGOXIN-IMMUNOACTIVITY/HYPERTENSIVE PREGNANCY
-
批准号:3352631
-
项目类别:
-
资助金额:$4.37万
-
财政年份:1986
-
负责人:Roland Valdes
-
依托单位:
ENDOGENOUS DIGOXIN-IMMUNOACTIVITY/HYPERTENSIVE PREGNANCY
-
批准号:3352627
-
项目类别:
-
资助金额:$14.56万
-
财政年份:1986
-
负责人:Roland Valdes
-
依托单位:
海外基金